PharmaSci
Timeline
20 events since 2015Board
Capital
Filings
Financial
Establishments
Address
201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 21 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0636973759
Annual accounts 2024 filed PDFabbreviated format · 29 days late
2024
Highest result from 2016 to 2025 net €116,038 ▲3.5% The operating result of €171,945 and the net result of €116,038 are both a record.
Annual accounts 2023 filed PDFabbreviated format · 26 days before the deadline
Registered office moved to RotselaarThe registered office moved to Stationsstraat 19 te 3110 Rotselaar · changes role from manager to director · “Beheer van apotheken; Managementactiviteiten van holdings:tussenkomen in het dagelijks bestuur…” (deed in Dutch) · General meeting of 29-12-20237 points ▸
- General meeting of 29-12-2023
- The registered office moved to Stationsstraat 19 te 3110 Rotselaar
- The capital is divided into 2,500 shares
- resigns as manager, not named in the articles
- appointed as director, not named in the articles
- Power of attorney granted to
- The registered office is at Stationsstraat 19 te 3110 Rotselaar
- The deed holds 5 more points.
2023
Annual accounts 2022 filed PDFabbreviated format · 24 days before the deadline
2022
Equity above €500,000 equity €541,901 ▲20.9% With a profit in every financial year since 2016, equity grows to €541,901.
Annual accounts 2021 filed PDFabbreviated format · 75 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 3 days before the deadline
2020
resigns as managerGeneral meeting of 08-11-20192 points ▸
- General meeting of 08-11-2019
- resigns as manager
Annual accounts 2019 filed PDFabbreviated format · 87 days before the deadline
2019
Equity above €200,000 equity €273,646 ▲48.7% With a profit in every financial year since 2016, equity grows to €273,646.
Annual accounts 2018 filed PDFabbreviated format · 67 days before the deadline
2018
Equity above €150,000 equity €184,022 ▲29.4% With a profit in every financial year since 2016, equity grows to €184,022.
Annual accounts 2017 filed PDFabbreviated format · 32 days before the deadline
2017
Equity above €100,000 equity €142,240 ▲53.4% With a profit in every financial year since 2016, equity grows to €142,240.
Annual accounts 2016 filed PDFabbreviated format · 44 days before the deadline
2015
IncorporationFounding capital of €18,600, 2,500 shares, €6,200 paid up · Founded by and · (manager) and (manager) appointed · published on 15-09-20156 points ▸
- Founded by
- Founded by
- The founding capital is euro 18.600, divided into 2,500 shares
- appointed as manager, not named in the articles
- appointed as manager, not named in the articles
- Pre-incorporation commitments, ratification, 01-08-2015
First establishment Steenweg op Gelrode 46, Rotselaar
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank